Zobrazeno 1 - 10
of 164
pro vyhledávání: '"Benjamin L. Cohen"'
Autor:
Benjamin Click, Edward L. Barnes, Benjamin L. Cohen, Bruce E. Sands, John S. Hanson, David T. Rubin, Marla C. Dubinsky, Miguel Regueiro, Derek Gazis, Julie M. Crawford, Millie D. Long
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Inflammatory bowel disease (IBD) treatment paradigms recommend objective disease activity assessment and reactive therapeutic drug monitoring (TDM) prior to changes in biologic therapy. We aimed to describe objective marker and TD
Externí odkaz:
https://doaj.org/article/c94a6d498f654c49b59bc62a2e6ffb57
Autor:
Stephan R. Vavricka, Thomas Greuter, Benjamin L. Cohen, Walter Reinisch, Flavio Steinwurz, Marc Fellmann, Xiang Guo, Nervin Lawendy, Jerome Paulissen, Laurent Peyrin-Biroulet
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). Here, we report steroid-free efficacy and safety with tofacitinib among patients with UC who received corticosteroids at baseline
Externí odkaz:
https://doaj.org/article/37c5068c68a84596aefa1ea91984fea2
Autor:
Siddharth Singh, Ashwin N. Ananthakrishnan, Nghia H. Nguyen, Benjamin L. Cohen, Fernando S. Velayos, Jennifer M. Weiss, Shahnaz Sultan, Shazia M. Siddique, Jeremy Adler, Karen A. Chachu
Publikováno v:
Gastroenterology. 164:344-372
Autor:
Gary R. Lichtenstein, Benjamin L. Cohen, Leonardo Salese, Irene Modesto, Wenjin Wang, Gary Chan, Haytham Mohamed Ahmed, Chinyu Su, Laurent Peyrin-Biroulet
Publikováno v:
Digestive Diseases and Sciences. 68:2624-2634
Autor:
Laurie Keefer, Tina Siganporia, Louis J. Cohen, Laura Manning, Ryan C. Ungaro, Benjamin L Cohen, Anthony Biello, Marla Dubinsky, Stacy Tse, Ksenia Gorbenko
Publikováno v:
Clinical Gastroenterology and Hepatology. 20:1831-1838
Background and Aims Integrated IBD care is effective but not routinely implemented. Validated methods that simultaneously address mind and body targets such as resilience may improve access and outcomes. We describe the development and implementation
Autor:
Benjamin L, Cohen, Phillip, Fleshner, Sunanda V, Kane, Hans H, Herfarth, Nicole, Palekar, Francis A, Farraye, Jonathan A, Leighton, Jeffry A, Katz, Russell D, Cohen, Mark E, Gerich, Raymond K, Cross, Peter D R, Higgins, Andrew, Tinsley, Sarah, Glover, Corey A, Siegel, Jaime L, Bohl, Heba, Iskandar, Jiayi, Ji, Liangyuan, Hu, Bruce E, Sands
Publikováno v:
Gastroenterology. 163:204-221
Whether preoperative treatment of inflammatory bowel disease (IBD) with tumor necrosis factor inhibitors (TNFis) increases the risk of postoperative infectious complications remains controversial. The primary aim of this study was to determine whethe
Autor:
Manik Aggarwal, Rajat Garg, Gopanandan Parthasarthy, Amy S. Nowacki, Ruthvik Padival, Arthur McCullough, Taha Qazi, Benjamin Click, Florian Rieder, Benjamin L. Cohen
Publikováno v:
Dig Dis Sci
BACKGROUND: Chronic inflammation in IBD is postulated to drive NAFLD progression from steatosis to fibrosis. AIMS: To study the histopathological spectrum of NAFLD in Crohn disease (CD) and Ulcerative colitis (UC). METHODS: Patients with biopsy prove
Autor:
Salam P Bachour, Ravi S Shah, Florian Rieder, Taha Qazi, Jean Paul Achkar, Jessica Philpott, Bret Lashner, Stefan D Holubar, Amy L Lightner, Edward L Barnes, Jordan Axelrad, Miguel Regueiro, Benjamin Click, Benjamin L Cohen
Publikováno v:
J Crohns Colitis
Background Postoperative recurrence [POR] of Crohn’s disease following ileocolonic resection is common. The impact of immediate postoperative intra-abdominal septic complications [IASC] on endoscopic and surgical recurrence has not been elucidated.
Autor:
Millie D Long, Anita Afzali, Monika Fischer, David Hudesman, Maisa Abdalla, Robert McCabe, Benjamin L Cohen, Ryan C Ungaro, Will Harlan, John Hanson, Gauree Konijeti, Steven Polyak, Timothy Ritter, Bruce Salzberg, Jennifer Seminerio, Emily English, Xian Zhang, Puza P Sharma, Hans H Herfarth
Publikováno v:
Inflammatory Bowel Diseases. 29:570-578
Background Tofacitinib is an oral, small-molecule JAK inhibitor for the treatment of ulcerative colitis (UC). Using a novel electronic reporting tool, we aimed to prospectively describe the onset of tofacitinib efficacy during induction therapy in a
Autor:
Joseph Carter Powers, Benjamin L Cohen, Florian Rieder, Benjamin H Click, Ruishen Lyu, Katherine Westbrook, Tracy Hull, Stefan Holubar, Miguel D Regueiro, Taha Qazi
Publikováno v:
Inflammatory Bowel Diseases.
Background Patients with an ileal pouch-anal anastomosis (IPAA) can experience pouch inflammation postoperatively. The use of antitumor necrosis factor (anti-TNF) biologics may be associated with pouch inflammation, but limited data exist on the impa